Treating a foot ulcer: One step in diabetic care
Vulvar ulcers: Patient characteristics, lesion morphology provide clues for easy diagnosis
Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gas
Medical News: Sucampo Reports Top-Line Results Of Phase 2 Clinical Trial Of Cobiprostone For Prevention Of NSA
Sucampo Reports Top-Line Results Of Phase 2 Clinical Trial Of Cobiprostone For Prevention Of NSAID-Induced Gas
POZEN Submits New Drug Application For VIMOVO' (PN 400)
POZEN Submits New Drug Application For VIMOVO (PN 400)
Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gas
Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gas
Sucampo Pharma (SCMP) Reports Top-Line Results from Phase 2 Trial of Cobiprostone
Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gas
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
Contest Offers Young Hockey Enthusiasts the Chance to Play with Fernando Pisani of the Edmonton Oilers
Peptic Ulcer Bacterium Alters The Body's Defence System
POZEN Submits New Drug Application For VIMOVO (PN 400)
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
Risk factors for colorectal cancer
POZEN Submits New Drug Application For VIMOVO (PN 400)
AstraZeneca Partner Pozen Submits PN400 New Drug Application (DJ)
